Thesis Care (Formerly Trovo Health) Raises $45M Series A Led by Oak HC/FT

Why It Matters

The influx of $105 million into AI‑driven health‑tech signals strong market confidence that these technologies can address capacity constraints and revenue inefficiencies across the healthcare system.

Key Takeaways

• Thesis Care raises $45M to scale AI clinical agents.
• Funding led by Oak HC/FT, total $60M invested.
• Adonis secures $40M Series C for AI RCM platform.
• Blossom Health lands $20M to expand telepsychiatry network.
• AI-driven health tech attracts $115M total new capital.

Pulse Analysis

Investors are pouring capital into artificial‑intelligence tools that promise to reshape how health systems operate. In the past twelve months, AI‑focused startups have attracted more than $100 million in new funding, reflecting a broader shift toward digital solutions that can augment limited clinical staff and streamline complex administrative workflows. This capital surge is driven by proven use cases—such as AI agents that triage patient intake, predictive analytics that reduce claim denials, and virtual platforms that expand mental‑health access—demonstrating tangible ROI for providers and payers alike.

Thesis Care’s $45 million Series A will fund commercial expansion of its AI care‑team agents, positioning the company to partner with a wider range of hospitals seeking to extend clinical capacity without proportional staffing increases. Meanwhile, Adonis’s $40 million Series C backs an AI orchestration platform designed to automate revenue‑cycle management, a pain point that costs U.S. hospitals billions annually in lost reimbursements. Blossom Health’s $20 million raise targets growth of its telepsychiatry network, leveraging AI to match patients with in‑network psychiatrists and streamline insurance verification, a critical need as mental‑health demand outpaces provider supply.

Collectively, these funding rounds highlight a market consensus that AI can deliver scalability, cost containment, and improved patient outcomes. For investors, the trend suggests a fertile landscape for further capital deployment, while health systems can expect accelerated adoption of AI tools that address workforce shortages and operational bottlenecks. As regulatory frameworks evolve and data integration improves, AI‑enabled health‑tech is poised to become a cornerstone of modern care delivery.

Deal Summary

Thesis Care, previously known as Trovo Health, secured $45 million in a Series A round led by Oak HC/FT, with participation from CRV and Black Opal Ventures. The funding brings the company's total capital to $60 million and will support commercial expansion and platform development.